Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome

Wiskott-Aldrich syndrome (WAS) is an inherited immunodeficiency caused by mutations in the gene encoding WASP, a protein regulating the cytoskeleton. Hematopoietic stem/progenitor cell (HSPC) transplants can be curative, but, when matched donors are unavailable, infusion of autologous HSPCs modified ex vivo by gene therapy is an alternative approach. We used a lentiviral vector encoding functional WASP to genetically correct HSPCs from three WAS patients and reinfused the cells after a reduced-intensity conditioning regimen. All three patients showed stable engraftment of WASP-expressing cells and improvements in platelet counts, immune functions, and clinical scores. Vector integration analyses revealed highly polyclonal and multilineage haematopoiesis resulting from the gene-corrected HSPCs. Lentiviral gene therapy did not induce selection of integrations near oncogenes, and no aberrant clonal expansion was observed after 20 to 32 months. Although extended clinical observation is required to establish long-term safety, lentiviral gene therapy represents a promising treatment for WAS.

Citing Articles

Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?.

Bhatia D, Dolcetti R, Mazzieri R J Exp Clin Cancer Res. 2025; 44(1):98.

PMID: 40089746 DOI: 10.1186/s13046-025-03359-x.

Analysis of Hepatic Lentiviral Vector Transduction: Implications for Preclinical Studies and Clinical Gene Therapy Protocols.

Hu P, Hao Y, Tang W, Diering G, Zou F, Kafri T Viruses. 2025; 17(2).

PMID: 40007031 PMC: 11861806. DOI: 10.3390/v17020276.

Viral-based gene therapy clinical trials for immune deficiencies and blood disorders from 2013 until 2023 - an overview.

Eshghi S, Mousakhan Bakhtiari M, Behfar M, Izadi E, Naji P, Jafari L Regen Ther. 2025; 28():262-279.

PMID: 39844821 PMC: 11751425. DOI: 10.1016/j.reth.2024.12.007.

Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial.

Khan A, Barber D, McKillop W, Rupar C, Auray-Blais C, Fraser G Clin Transl Med. 2025; 15(1):e70073.

PMID: 39794302 PMC: 11726700. DOI: 10.1002/ctm2.70073.

Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration.

Xie K, Starzyk J, Majumdar I, Wang J, Rincones K, Tran T Nat Biotechnol. 2024; .

PMID: 39663372 DOI: 10.1038/s41587-024-02504-9.

References

Bystrykh L, Verovskaya E, Zwart E, Broekhuis M, de Haan G . Counting stem cells: methodological constraints. Nat Methods. 2012; 9(6):567-74. DOI: 10.1038/nmeth.2043. View

Hacein-Bey-Abina S, Garrigue A, Wang G, Soulier J, Lim A, Morillon E . Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest. 2008; 118(9):3132-42. PMC: 2496963. DOI: 10.1172/JCI35700. View

Biasco L, Baricordi C, Aiuti A . Retroviral integrations in gene therapy trials. Mol Ther. 2012; 20(4):709-16. PMC: 3321603. DOI: 10.1038/mt.2011.289. View

Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T . Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 2013; 341(6148):1233158. DOI: 10.1126/science.1233158. View

Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F . Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature. 2010; 467(7313):318-22. PMC: 3355472. DOI: 10.1038/nature09328. View

Cattoglio C, Facchini G, Sartori D, Antonelli A, Miccio A, Cassani B . Hot spots of retroviral integration in human CD34+ hematopoietic cells. Blood. 2007; 110(6):1770-8. DOI: 10.1182/blood-2007-01-068759. View

Deichmann A, Brugman M, Bartholomae C, Schwarzwaelder K, Verstegen M, Howe S . Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy. Mol Ther. 2011; 19(11):2031-9. PMC: 3222531. DOI: 10.1038/mt.2011.178. View

Cui K, Zang C, Roh T, Schones D, Childs R, Peng W . Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell. 2009; 4(1):80-93. PMC: 2785912. DOI: 10.1016/j.stem.2008.11.011. View

Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang G, Berry C . Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2010; 363(4):355-64. PMC: 2957288. DOI: 10.1056/NEJMoa1000164. View

10.

Astrakhan A, Sather B, Ryu B, Khim S, Singh S, Humblet-Baron S . Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome. Blood. 2012; 119(19):4395-407. PMC: 3362358. DOI: 10.1182/blood-2011-03-340711. View

11.

Scaramuzza S, Biasco L, Ripamonti A, Castiello M, Loperfido M, Draghici E . Preclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome. Mol Ther. 2012; 21(1):175-84. PMC: 3538318. DOI: 10.1038/mt.2012.23. View

12.

Modlich U, Navarro S, Zychlinski D, Maetzig T, Knoess S, Brugman M . Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther. 2009; 17(11):1919-28. PMC: 2835038. DOI: 10.1038/mt.2009.179. View

13.

Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L . Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med. 2009; 360(5):447-58. DOI: 10.1056/NEJMoa0805817. View

14.

Cattoglio C, Pellin D, Rizzi E, Maruggi G, Corti G, Miselli F . High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. Blood. 2010; 116(25):5507-17. DOI: 10.1182/blood-2010-05-283523. View

15.

Sauer A, Brigida I, Carriglio N, Hernandez R, Scaramuzza S, Clavenna D . Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID. Blood. 2011; 119(6):1428-39. PMC: 3426348. DOI: 10.1182/blood-2011-07-366781. View

16.

Orange J, Roy-Ghanta S, Mace E, Maru S, Rak G, Sanborn K . IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function. J Clin Invest. 2011; 121(4):1535-48. PMC: 3069781. DOI: 10.1172/JCI44862. View

17.

Wang G, Ciuffi A, Leipzig J, Berry C, Bushman F . HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. 2007; 17(8):1186-94. PMC: 1933515. DOI: 10.1101/gr.6286907. View

18.

Stein S, Ott M, Schultze-Strasser S, Jauch A, Burwinkel B, Kinner A . Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med. 2010; 16(2):198-204. DOI: 10.1038/nm.2088. View

19.

Biffi A, Bartolomae C, Cesana D, Cartier N, Aubourg P, Ranzani M . Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood. 2011; 117(20):5332-9. DOI: 10.1182/blood-2010-09-306761. View

20.

Marangoni F, Trifari S, Scaramuzza S, Panaroni C, Martino S, Notarangelo L . WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J Exp Med. 2007; 204(2):369-80. PMC: 2118740. DOI: 10.1084/jem.20061334. View